(Q57569335)

2

0 references

author name string

J. Gavalda

1

0 references

R. San Juan

3

0 references

J. M. Aguado

4

0 references

J. Fortun

5

0 references

A. Moreno

7

0 references

P. Munoz

8

0 references

M. Blanes

9

0 references

A. Ramos

10

0 references

G. Rufi

11

0 references

M. Gurgui

12

0 references

J. Torre-Cisneros

13

0 references

M. Montejo

14

0 references

M. Cuenca-Estrella

15

0 references

J. L. Rodriguez-Tudela

16

0 references

A. Pahissa

Clinical Infectious Diseases

17

0 references

language of work or name

English

0 references

publication date

1 July 2005

0 references

published in

0 references

volume

41

0 references

issue

1

0 references

page(s)

52-59

0 references

cites work

The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants

1 reference

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

Risk factors for systemic fungal infections in liver transplant recipients

21 January 2018

1 reference

Risk factors for invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

21 January 2018

1 reference

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

21 January 2018

1 reference

Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients

21 January 2018

1 reference

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses.

21 January 2018

1 reference

Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis

21 January 2018

1 reference

Invasive aspergillosis in transplant recipients

21 January 2018

1 reference

Hepatitis C virus infection and liver transplantation

21 January 2018

1 reference

Liver transplantation in hepatitis C virus-related cirrhosis.

21 January 2018

1 reference

Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection

21 January 2018

1 reference

Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors

21 January 2018

1 reference

Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients

21 January 2018

1 reference

Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients

21 January 2018

1 reference

Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients

21 January 2018

1 reference